SciTree Final Report

516 views

Published on

Final Report for the Venture lab

Published in: Business, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
516
On SlideShare
0
From Embeds
0
Number of Embeds
83
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

SciTree Final Report

  1. 1. Elena Kalmykova John Noel M. ViañaWhy we do this
  2. 2. New technologies (materials, Scientific networks have no contact orsubstances, technique) are a basis crossing with investors’ networks.of contemporary economy and anideal target for investment. Scientific Output comes in form ofScience produces plenty of new verbose papers, inaccessible andtechnologies, which can be incomprehensible for people outsideconverted into business product, of academy.and create revenue. However investors do not Investors’ Input comes in form of have direct access to simple and short presentations and information about new business plans, which scientists are technologies worldwide. It not used to make. especially concerns cutting edge technologies, produced The organizations mediating in the third-world countries. partnerships between science and business work with European andThere is a gap between American scientists, neglectingScience and business, technology from lesser-known regionsbetween new technologies and developing countries.and their implementation tosolve real world problems.Problem Reasons
  3. 3. SciTree A web platform for collaboration between scientists and investors• Changing scientific Output :short statementabout new technology (150 words)+ link to apaper. As our surveys have shown, it’s thebest format for scientists and investors.• Investors can find an expertise for newtechnologies, look for a technology they wantto turn into a product, buy patents• Big companies can find a research group forhiring and investment•We provide brokering between scientists andinvestors• Constant monitoring of new technologiesSolution
  4. 4. Over 5 million scientists are developing new technologies (biology, medicine, materials, etc). Scientists get financing by writing articles for peer-review journals and project proposals for research funds (government organizations), which takes up to 50% of their working time. This is ineffective usage of their time and brainpower.Companies spend up to 43% of revenue on R&D (Allergan –43.4%, Eriksson – 24.9%). New technologies are important forprogress and successful competition. Big companies arehunting for new technologies. But they miss all perspective andgroundbreaking technologies from the third world, as there areno platforms giving access to these technologies. With SciTree entire science can be used as your own R&D department. Outsource your R&D globally.Market
  5. 5. •Research groups and scientists in the academeKey Partnerships •Investment firms and investors •Science and technology-oriented companies •Creation and maintenance of SciTree’s website •Establishment of contacts and registered users Key Activities from the industry and academe •Networking with Investors, S&T companies •Web hosting, CMS, database Key Resources •Contacts both in the industry and academe •Network of investors and scientists •Resource personnel and Technical staff •Environment for interdisciplinary scientific work and direct communication with investors and S&T companies Value •Problem-based organization of Science research •Venue for outlicensing patented technologies and Propositions brokering of academe-industry partnerships (Non- Disclosure Agreements) •Updates from scientists from all around the world •Concise, brief, and reputable Science newsBusiness Model
  6. 6. Customer •Correspondence (e-mail, written letters) with scientists, investors, and companiesRelationships •Featuring cases of successful partnerships • Internet; flyers and brochures; booths in scientific conferences; direct contact with universities and Channels Technological Transfer Offices; communication (direct or e-mail dropshots) with investors and S&T companies Customer •Scientists and Academics looking for external funding Segments •Investors and S&T companies looking to outsource patented technologies and collaborate with the academe •Web hosting, site design, and database managementCost Structure •Advertisements and marketing in scientific conferences •Recruitment of skilled professionals and technical staff •Participation fees in actual networking events •Targeted advertising (Google Ads) Revenue •Membership and monthly subscription fees to investor- Streams specific Science news and updates •Brokering of academe and industry partnershipsBusiness Model
  7. 7. Investors:pay for subscription (golden and Advertising: targeted ads silver membership), exclusive (lab equipment, laptops etc) access to database of patents and community of experts Investors: pay for review of dynamics of field Scientists: pay to promote development, analytics, consu your news or team lting and selection of teams for investment Brokering of partnerships Universities: pay for between scientists and advertising academic jobs investorsMarketing
  8. 8. Risks Funding Sources• Lack of interest of customers to SciTree 1. Large foundations that Strategy: Keeping track of user opinions support scientific structure regarding SciTree and applying them development efforts• Failure of Online Brokering 2. International Grant-giving Strategy: Focus on Other Revenue Streams Agencies (European FP7 Capacities programme)• Competitors copying or simulating 3. Individuals (venture features unique to SciTree capitalists, business Strategy: Improve our proposition to the customers and improve service angels)Social network for Social network for A consultancyscientists, 1.7 million users. scientists, 1.8 million firm, Deficiencies: highDeficiencies: scientists users. Deficiencies: price, lack ofonly, output in a form of big scientists only, output in transparency, lack ofarticles. a form of big articles. direct contacts with scientists, no third-world technologies.Competitors
  9. 9. Dr. Reynaldo Garcia, mentorProfessor of Molecular Biology and Biotechnology at University of the Philippines DilimanDirector, Technology Transfer and Business Development Office at University of the Philippines.Has experience working as UK Biotech Consultant/Business Intelligence Provider at FreelanceBioscience Key Account Manager at London Biotechnology Network SystemDr. Elena Kalmykova, CEOPhD in Philosophy (Uppsala University, Sweden). Graduated from Oriental and PhilosophyFaculties at Saint-Petersburg State University.Courses attended: Technology Entrepreneurship (Stanford University), Researchers andLeadership (Swedish Institute). Published over 20 papers on the topics such as structure ofscientific knowledge and communication in science.Work experience in web-projects: Electric Jungle (Sun Microsystems), SMM, webdesign, member of Wallenberg Calendar team.John Noel M. Viaña, CMOBS in Molecular Biology and Biotechnology (University of the Philippines - Diliman).Has worked at the Laboratory of Molecular and Cell Biology at the National Institute of MolecularBiology and Biotechnology, UP DilimanMember of international honor societies (Phi Kappa Phi and Phi Sigma Biological Sciences HonorSociety). Courses attended: Technological Entrepreneurship at Stanford’s Venture Lab.Syrgak Turgumbaev, CTOBS in Computer Science (Kyrgyz State Technical University)Has 4 year work experience as software developer at Xponaut AB, Sweden and 2.5 year experienceas web consultant at ModularStreams Sweden AB. Working with Drupal, PHP, Flex, CSS3, HTML5,programming language: C++. Team

×